Xantinol nicotinate
Jump to navigation
Jump to search
| Combination of | |
|---|---|
| Xanthinol | vasodilator |
| [[{{{component3}}}]] | ? Class |
| [[{{{component4}}}]] | ? Class |
| [[{{{component5}}}]] | ? Class |
| [[{{{component6}}}]] | ? Class |
| Gene therapy | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Identifiers | |
| PubChem Template:Abbreviation | |
| UNII | |
| KEGG | |
| Chemical and physical data | |
Template:Xmark (what is this?) (verify) | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Xantinol nicotinate (or xanthinol niacinate) is a vasodilator. It is a combination of xanthinol and niacin (nicotinic acid).[1]
References
- ↑ Xanthinol niacinate at cancerweb.ncl.ac.uk
Categories:
- Articles with short description
- Template:drugs.com link with non-standard subpage
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugs that are a combination of chemicals
- Vasodilators
- Nicotinates
- Drug